News|Videos|January 20, 2025
Your Guide to 2025: Pharma, Formularies, the Pipeline and More
Advertisement
This webinar, “Your Guide to 2025: Pharma, Formularies, the Pipeline and More” featured Luke Greenwalt, MBA,vice president and lead of the Market Access Center of Excellence at IQVIA, an Jeff Casberg, RPh, M.S., senior vice president, clinical pharmacy at IPD Analytics. Greenwalt and Casberg, both of whom are on the Managed Healthcare Executive editorial advisory board, discussed the market trends for GLP-1s and biosimilars; the ’25 drug pipeline; and the prospects for PBM legislation.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
Medicaid tech companies pledge $600 million to help states update systems
4
Why the great pharma-MedTech divide is healthcare’s biggest miss
5



















